Developer docs
API playgroundTry for free, no card

Search company profiles

Nesplora

Full company profile

uuid0004m3x

Namestring
Nesplora
Legal namestring
GIUNTI NESPLORA, S.L.
Websiteurl
nesplora.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Nesplora (legal entity GIUNTI NESPLORA, S.L.) is a privately held Spanish company founded in 2008 in San Sebastián (Donostia), Spain, that develops virtual-reality-based neuropsychological assessment software. The platform comprises five CE-marked medical devices — Aula and Aula School for pediatric attention assessment (ages 6–16), Aquarium for adult attention and cognitive flexibility (ages 16+), Ice Cream for executive functions (ages 8+), and Memory Suite for memory evaluation (ages 12–90) — that run exclusively on Meta Quest VR headsets and generate automated clinical reports in under 30 minutes. Underlying the products are proprietary VR environments, normative studies with 676–1,469 participants per test, and 600+ scientific publications supporting validation across 15+ languages and 30+ countries. The company distributes exclusively through its own e-commerce website (nesplora.com) and direct sales, with a sales contact (customers@nesplora.com) handling enterprise accounts of 3+ centers. The pricing model is multi-tiered subscription (BITS pay-per-use, Essential, Professional, Enterprise) billed monthly/quarterly/annually with no entry fee and €50 reactivation fees for lapsed licenses. Nesplora holds an exclusive sublicensing arrangement with Giunti Psychometrics S.r.l. (which owns the underlying platform), has received ~$1.54M in European Horizon 2020/EISMEA funding, and transitions its delivery to a cloud WebApp on AWS Ireland starting in 2024–2025. The company operates with 11–50 employees serving primarily neuropsychologists, clinical psychologists, educational psychologists, psychiatrists, and neurologists.

Short descriptiontext

Nesplora develops CE-marked VR-based neuropsychological assessment software (Aula, Aquarium, Ice Cream, Memory Suite) running on Meta Quest headsets. It serves neuropsychologists, clinical psychologists, psychiatrists, and educational professionals in 30+ countries via subscription tiers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDonostia-san Sebastián, Spain
HQ citystring
Donostia-san Sebastián
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
virtual reality assessment, neuropsychological evaluation software, VR cognitive testing, ADHD diagnostic tools, memory assessment platform
Industry2 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAJ
Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Neuropsychological Assessment Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Plans (Essential, Professional)
TypeSubscription Recurring
Description

Recurring subscription plans with no entry fee, billed monthly, quarterly, or annually depending on chosen modality. No permanence - can cancel or change plans anytime. Plans include all tests and features, with prices adapted to the size of the clinic or hospital.

nesplora.com
2BITS Plan (Pay-per-use)
TypeUsage Based
Description

Initial plan without recurrent payment, with an initial registration fee and pay-per-use on demand. One use equals one results report generated from a neuropsychological assessment.

nesplora.com
3Enterprise Licenses
TypeSubscription Recurring
Description

Corporate accounts for 3 or more centers with volume discounts. License is associated with a single VR device; multi-device offers available for the same center.

nesplora.com
4Reactivation Fees
TypeSubscription Recurring
Description

Reactivation fee of fifty euros (€50.00) for clients exceeding three consecutive months without an active license.

nesplora.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details5 tiers
1BITS Plan - Pay-per-use model with initial registration fee
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Initial registration fee with pay-per-use pricing on demand. No recurring payment. One use equals one results report.

nesplora.com
2Essential Plan - Subscription for individual centers
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly, quarterly, or annual billing options. No entry fee. Includes all tests. Prices adapted to clinic/hospital size.

nesplora.com
3Professional Plan - Premium subscription tier
ModelSubscriptionBilling cadenceMonthly
Notes

Higher tier subscription with enhanced features. Monthly, quarterly, or annual billing. Prices adapted to clinic/hospital size.

nesplora.com
4Enterprise Plan - Multi-center corporate accounts (3+ centers)
ModelSubscriptionBilling cadenceAnnual
Notes

Volume discounts for 3 or more centers. Contact sales for custom pricing.

nesplora.com
5Reactivation Fee
ModelOtherBilling cadenceOne time/ perpetual license
Notes

€50.00 reactivation fee for accounts exceeding 3 consecutive months without active license.

nesplora.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Nesplora Memory Suite
Description

Virtual reality-based memory assessment test for ages 12 to 90, evaluating different components of memory for diagnosis of dementias and memory disorders.

nesplora.com
+4 more records
Core offering1 text field

Nesplora develops a virtual reality-based neuropsychological assessment software platform that enables mental health professionals to evaluate cognitive functions including attention, impulsivity, motor activity, executive functions, and memory. The platform consists of five VR test products (Aula, Aula School, Aquarium, Ice Cream, Memory Suite) that run on Meta Quest headsets and generate automatic clinical reports with quantitative data, used to support diagnosis of ADHD, dementia, and other cognitive or neurodevelopmental conditions. The software is CE-marked as a medical device, supports 15+ languages, and is sold via subscription and pay-per-use plans to clinics, hospitals, and practitioners worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Automatic results in less than 30 minutes
+2 more records
Product overview1 text field

Nesplora is a virtual reality-based neuropsychological assessment platform consisting of five VR products designed to evaluate cognitive functions across the lifespan. The core portfolio includes Nesplora Aula and Aula School for children's attention assessment (ages 6-16), Nesplora Aquarium for adult attention and cognitive flexibility (ages 16+), Nesplora Ice Cream for executive functions assessment (ages 8+), and Nesplora Memory Suite for comprehensive memory evaluation (ages 12-90). All tests are administered using Meta Quest VR headsets and generate automatic reports with quantitative data, graphs, and clinical interpretations. The platform operates on a subscription model with various pricing plans (BITS, Essential, Professional) and requires a VR headset, computer/tablet, and Wi-Fi connection.

Product and service5 records
1Nesplora Aula
CategoryVR neuropsychological assessment
Description

VR-based neuropsychological assessment test for children aged 6 to 16, evaluating attentional processes, impulsivity, and motor activity to support diagnosis of ADHD and other neurodevelopmental conditions. Includes standard neuropsychological, school-focused (Aula School), and family-friendly (Aula Family) report variants.

2Nesplora Aula School
CategoryVR neuropsychological assessment
Description

School-focused VR assessment adapting the Aula format for school counselors and educational psychologists, providing cognitive-attentional profiles with actionable classroom recommendations.

3Nesplora Aquarium
CategoryVR neuropsychological assessment
Description

VR-based assessment for adults aged 16 and above providing complete evaluation of attentional processes, impulsivity, working memory, and cognitive flexibility, oriented toward adult pathologies and transitory states such as anxiety or depression.

4Nesplora Ice Cream
CategoryVR neuropsychological assessment
Description

VR-based executive functions test measuring different components of executive functions and learning for ages 8 and up, providing information for diagnosis of dysexecutive syndromes and pathologies with frontal involvement.

5Nesplora Memory Suite
CategoryVR neuropsychological assessment
Description

VR-based memory assessment test evaluating immediate, short-term, working, prospective, retrospective, visual, and auditory memory components in a virtual home environment for ages 12 to 90, supporting diagnosis of dementia and memory function disorders. Test duration: 20-23 minutes.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Giunti Psychometrics S.r.l. owns the Nesplora Platform and has granted Giunti Nesplora S.L. an exclusive license to distribute and sublicense the platform. The Nesplora Platform is software exclusively owned by Giunti Psychometrics S.r.l. under exclusive license by Giunti Nesplora S.L., which may grant non-exclusive, non-transferable sublicenses to customers.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration and educational purposes.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration and educational purposes.

4Universidad de Oviedo
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration and educational purposes.

nesplora.com
5Universidad Autónoma de Barcelona
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration and educational purposes.

nesplora.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration and educational purposes.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for research collaboration and educational purposes.

Strategic tierCoreTypeTechnology or Integration
Description

Nesplora's tests run exclusively on Meta Quest VR headsets (Quest 2, Quest 3, Quest 3S, Quest Pro). The Nesplora app is compatible with Meta's VR ecosystem, and the company has received Meta Quest 3S certification.

Strategic tierCoreTypeTechnology or Integration
Description

Cloud data storage for the new WebApp platform (clients from 2025) is hosted on AWS servers located in Dublin, Ireland. Data is encrypted in transit (TLS) and at rest (AES-256).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Creyos offers a digital cognitive assessment platform used by clinicians and researchers to measure attention, memory, and executive function. Direct competitor in computerized neuropsychological assessment with similar target customer base of clinicians and similar online delivery model.

TypeDirect peer
Description

CNS Vital Signs provides computerized neurocognitive assessment batteries for clinicians, measuring memory, attention, executive function, and mood. Closely comparable on product offering (computerized neurocognitive battery), target customer (clinicians), and clinical use case (ADHD, dementia, TBI).

3Pear Therapeutics (precedent)
TypeBroad incumbent
Description

Pear Therapeutics was a pioneer in prescription digital therapeutics (PDTs/SaMD), with FDA-cleared products for various neurological and psychiatric conditions. Comparable as a regulated digital therapeutics company addressing cognitive/behavioral health, though broader in therapeutic scope.

TypeDirect peer
Description

Akili Interactive develops FDA-cleared digital therapeutics for cognitive dysfunction, including ADHD (EndeavorRx). Direct competitor in regulated digital cognitive assessment/intervention, with comparable regulatory strategy (SaMD) and target indications in attention disorders.

TypeBroad incumbent
Description

PAR is a major incumbent publisher of psychological and neuropsychological assessment instruments used by clinicians. Comparable as a provider of standardized assessment tools to the same neuropsychologist/psychologist customer base, though primarily delivering traditional paper/digital tools.

TypeBroad incumbent
Description

Pearson Clinical publishes widely-used neuropsychological instruments (e.g., WAIS, WMS) and the Q-interactive/Q-global digital platforms. Large incumbent in the clinical assessment space competing for the same clinician budget that Nesplora targets.

TypeEmerging player
Description

Altoida uses AR/AI on smartphones/tablets to assess cognitive function and predict risk of Alzheimer's and other neurological conditions. Comparable as an emerging technology-driven cognitive assessment competitor with FDA breakthrough designation, though using AR rather than VR.

TypeBroad incumbent
Description

Posit Science offers BrainHQ, a cognitive training and assessment platform with clinical validation in healthy aging and cognitive decline. Comparable on the cognitive assessment/training domain with scientific backing, though focused on training rather than diagnostic assessment.

TypeEmerging player
Description

Winterlight Labs develops speech-based digital biomarkers for cognitive impairment, including Alzheimer's and other dementias. Comparable as an emerging digital health company applying novel technology to cognitive assessment, addressing overlapping dementia/aging indications.

10Mindstrong (precedent)
TypeEmerging player
Description

Mindstrong was an emerging player in digital phenotyping for mental health and cognitive assessment using smartphone interactions. Comparable as a technology-driven cognitive assessment startup, though pivoted/wound down — illustrating the capital intensity challenges in this space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nesplora

Neuropsychological Assessment Softwarenesplora.com

Nesplora develops CE-marked VR-based neuropsychological assessment software (Aula, Aquarium, Ice Cream, Memory Suite) running on Meta Quest headsets. It serves neuropsychologists, clinical psychologists, psychiatrists, and educational professionals in 30+ countries via subscription tiers.

What Nesplora does

Nesplora (legal entity GIUNTI NESPLORA, S.L.) is a privately held Spanish company founded in 2008 in San Sebastián (Donostia), Spain, that develops virtual-reality-based neuropsychological assessment software. The platform comprises five CE-marked medical devices — Aula and Aula School for pediatric attention assessment (ages 6–16), Aquarium for adult attention and cognitive flexibility (ages 16+), Ice Cream for executive functions (ages 8+), and Memory Suite for memory evaluation (ages 12–90) — that run exclusively on Meta Quest VR headsets and generate automated clinical reports in under 30 minutes. Underlying the products are proprietary VR environments, normative studies with 676–1,469 participants per test, and 600+ scientific publications supporting validation across 15+ languages and 30+ countries. The company distributes exclusively through its own e-commerce website (nesplora.com) and direct sales, with a sales contact (customers@nesplora.com) handling enterprise accounts of 3+ centers. The pricing model is multi-tiered subscription (BITS pay-per-use, Essential, Professional, Enterprise) billed monthly/quarterly/annually with no entry fee and €50 reactivation fees for lapsed licenses. Nesplora holds an exclusive sublicensing arrangement with Giunti Psychometrics S.r.l. (which owns the underlying platform), has received ~$1.54M in European Horizon 2020/EISMEA funding, and transitions its delivery to a cloud WebApp on AWS Ireland starting in 2024–2025. The company operates with 11–50 employees serving primarily neuropsychologists, clinical psychologists, educational psychologists, psychiatrists, and neurologists.

Nesplora firmographics

Firmographics
Name
Nesplora
Legal name
GIUNTI NESPLORA, S.L.
Website
https://nesplora.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
Nesplora develops CE-marked VR-based neuropsychological assessment software (Aula, Aquarium, Ice Cream, Memory Suite) running on Meta Quest headsets. It serves neuropsychologists, clinical psychologists, psychiatrists, and educational professionals in 30+ countries via subscription tiers.
Ownership category
akta.pro rank

Nesplora industry classification

Industry
Product category
Neuropsychological Assessment Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAJ
Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms

Keywords

  • Virtual reality assessment
  • Neuropsychological evaluation software
  • VR cognitive testing
  • ADHD diagnostic tools
  • Memory assessment platform

Where Nesplora is headquartered

Location

Headquarters

HQ city
Donostia-san Sebastián
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

Nesplora business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Subscription Plans (Essential, Professional): Recurring subscription plans with no entry fee, billed monthly, quarterly, or annually depending on chosen modality. No permanence - can cancel or change plans anytime. Plans include all tests and features, with prices adapted to the size of the clinic or hospital.
  2. BITS Plan (Pay-per-use): Initial plan without recurrent payment, with an initial registration fee and pay-per-use on demand. One use equals one results report generated from a neuropsychological assessment.
  3. Enterprise Licenses: Corporate accounts for 3 or more centers with volume discounts. License is associated with a single VR device; multi-device offers available for the same center.
  4. Reactivation Fees: Reactivation fee of fifty euros (€50.00) for clients exceeding three consecutive months without an active license.

Pricing tiers

ModelBillingPrice
Usage-basedPay-as-you-goBITS Plan - Pay-per-use model with initial registration fee
SubscriptionMonthlyEssential Plan - Subscription for individual centers
SubscriptionMonthlyProfessional Plan - Premium subscription tier
SubscriptionAnnualEnterprise Plan - Multi-center corporate accounts (3+ centers)
OtherOne time/ perpetual licenseReactivation Fee

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Nesplora product offering

Product offering

Core offering

Nesplora develops a virtual reality-based neuropsychological assessment software platform that enables mental health professionals to evaluate cognitive functions including attention, impulsivity, motor activity, executive functions, and memory. The platform consists of five VR test products (Aula, Aula School, Aquarium, Ice Cream, Memory Suite) that run on Meta Quest headsets and generate automatic clinical reports with quantitative data, used to support diagnosis of ADHD, dementia, and other cognitive or neurodevelopmental conditions. The software is CE-marked as a medical device, supports 15+ languages, and is sold via subscription and pay-per-use plans to clinics, hospitals, and practitioners worldwide.

Product overview

Nesplora is a virtual reality-based neuropsychological assessment platform consisting of five VR products designed to evaluate cognitive functions across the lifespan. The core portfolio includes Nesplora Aula and Aula School for children's attention assessment (ages 6-16), Nesplora Aquarium for adult attention and cognitive flexibility (ages 16+), Nesplora Ice Cream for executive functions assessment (ages 8+), and Nesplora Memory Suite for comprehensive memory evaluation (ages 12-90). All tests are administered using Meta Quest VR headsets and generate automatic reports with quantitative data, graphs, and clinical interpretations. The platform operates on a subscription model with various pricing plans (BITS, Essential, Professional) and requires a VR headset, computer/tablet, and Wi-Fi connection.

Differentiator

Problem solved

Functional benefit

Brands

  • Nesplora Memory Suite: Virtual reality-based memory assessment test for ages 12 to 90, evaluating different components of memory for diagnosis of dementias and memory disorders.
  • Aula
  • Aula School
  • Aquarium
  • Ice Cream

Products and services

  • Nesplora Aula VR-based neuropsychological assessment test for children aged 6 to 16, evaluating attentional processes, impulsivity, and motor activity to support diagnosis of ADHD and other neurodevelopmental conditions. Includes standard neuropsychological, school-focused (Aula School), and family-friendly (Aula Family) report variants.
  • Nesplora Aula School School-focused VR assessment adapting the Aula format for school counselors and educational psychologists, providing cognitive-attentional profiles with actionable classroom recommendations.
  • Nesplora Aquarium VR-based assessment for adults aged 16 and above providing complete evaluation of attentional processes, impulsivity, working memory, and cognitive flexibility, oriented toward adult pathologies and transitory states such as anxiety or depression.
  • Nesplora Ice Cream VR-based executive functions test measuring different components of executive functions and learning for ages 8 and up, providing information for diagnosis of dysexecutive syndromes and pathologies with frontal involvement.
  • Nesplora Memory Suite VR-based memory assessment test evaluating immediate, short-term, working, prospective, retrospective, visual, and auditory memory components in a virtual home environment for ages 12 to 90, supporting diagnosis of dementia and memory function disorders. Test duration: 20-23 minutes.

Quantifiable outcome

  • Automatic results in less than 30 minutes
  • +2 more outcomes

Companies that use Nesplora

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Nesplora technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature8 records

Nesplora partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Giunti Psychometrics S.r.l.coreOEM/ Whitelabel/ Licensing PartnerGiunti Psychometrics S.r.l. owns the Nesplora Platform and has granted Giunti Nesplora S.L. an exclusive license to distribute and sublicense the platform. The Nesplora Platform is software exclusively owned by Giunti Psychometrics S.r.l. under exclusive license by Giunti Nesplora S.L., which may grant non-exclusive, non-transferable sublicenses to customers.
  • Universidad ISEPminorStrategic or Co-development PartnerAcademic partnership for research collaboration and educational purposes.
  • Universidad EuropeaminorStrategic or Co-development PartnerAcademic partnership for research collaboration and educational purposes.
  • Universidad de OviedominorStrategic or Co-development PartnerAcademic partnership for research collaboration and educational purposes.
  • Universidad Autónoma de BarcelonaminorStrategic or Co-development PartnerAcademic partnership for research collaboration and educational purposes.
  • UCL (University College London)minorStrategic or Co-development PartnerAcademic partnership for research collaboration and educational purposes.
  • RMIT UniversityminorStrategic or Co-development PartnerAcademic partnership for research collaboration and educational purposes.
  • Meta (Facebook Technologies)coreTechnology or IntegrationNesplora's tests run exclusively on Meta Quest VR headsets (Quest 2, Quest 3, Quest 3S, Quest Pro). The Nesplora app is compatible with Meta's VR ecosystem, and the company has received Meta Quest 3S certification.
  • AWS (Amazon Web Services)coreTechnology or IntegrationCloud data storage for the new WebApp platform (clients from 2025) is hosted on AWS servers located in Dublin, Ireland. Data is encrypted in transit (TLS) and at rest (AES-256).

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Nesplora competitors and assessment

Company assessment

Direct peers

  • Creyos (formerly Cambridge Brain Sciences): Creyos offers a digital cognitive assessment platform used by clinicians and researchers to measure attention, memory, and executive function. Direct competitor in computerized neuropsychological assessment with similar target customer base of clinicians and similar online delivery model.
  • CNS Vital Signs: CNS Vital Signs provides computerized neurocognitive assessment batteries for clinicians, measuring memory, attention, executive function, and mood. Closely comparable on product offering (computerized neurocognitive battery), target customer (clinicians), and clinical use case (ADHD, dementia, TBI).
  • Akili Interactive: Akili Interactive develops FDA-cleared digital therapeutics for cognitive dysfunction, including ADHD (EndeavorRx). Direct competitor in regulated digital cognitive assessment/intervention, with comparable regulatory strategy (SaMD) and target indications in attention disorders.

Broad incumbents

  • Pear Therapeutics (precedent): Pear Therapeutics was a pioneer in prescription digital therapeutics (PDTs/SaMD), with FDA-cleared products for various neurological and psychiatric conditions. Comparable as a regulated digital therapeutics company addressing cognitive/behavioral health, though broader in therapeutic scope.
  • PAR (Psychological Assessment Resources): PAR is a major incumbent publisher of psychological and neuropsychological assessment instruments used by clinicians. Comparable as a provider of standardized assessment tools to the same neuropsychologist/psychologist customer base, though primarily delivering traditional paper/digital tools.
  • Pearson Clinical Assessment: Pearson Clinical publishes widely-used neuropsychological instruments (e.g., WAIS, WMS) and the Q-interactive/Q-global digital platforms. Large incumbent in the clinical assessment space competing for the same clinician budget that Nesplora targets.
  • Posit Science (BrainHQ): Posit Science offers BrainHQ, a cognitive training and assessment platform with clinical validation in healthy aging and cognitive decline. Comparable on the cognitive assessment/training domain with scientific backing, though focused on training rather than diagnostic assessment.

Emerging players

  • Altoida: Altoida uses AR/AI on smartphones/tablets to assess cognitive function and predict risk of Alzheimer's and other neurological conditions. Comparable as an emerging technology-driven cognitive assessment competitor with FDA breakthrough designation, though using AR rather than VR.
  • Winterlight Labs: Winterlight Labs develops speech-based digital biomarkers for cognitive impairment, including Alzheimer's and other dementias. Comparable as an emerging digital health company applying novel technology to cognitive assessment, addressing overlapping dementia/aging indications.
  • Mindstrong (precedent): Mindstrong was an emerging player in digital phenotyping for mental health and cognitive assessment using smartphone interactions. Comparable as a technology-driven cognitive assessment startup, though pivoted/wound down — illustrating the capital intensity challenges in this space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Nesplora social profiles

Digital presence

Nesplora compliance and trust

Trust signal

Compliance4 records

Nesplora financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nesplora leadership team

Management profile

Number of profiles

Profiles1 record

Nesplora funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nesplora M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nesplora

What does Nesplora do?

Nesplora develops a virtual reality-based neuropsychological assessment software platform that enables mental health professionals to evaluate cognitive functions including attention, impulsivity, motor activity, executive functions, and memory. The platform consists of five VR test products (Aula, Aula School, Aquarium, Ice Cream, Memory Suite) that run on Meta Quest headsets and generate automatic clinical reports with quantitative data, used to support diagnosis of ADHD, dementia, and other cognitive or neurodevelopmental conditions. The software is CE-marked as a medical device, supports 15+ languages, and is sold via subscription and pay-per-use plans to clinics, hospitals, and practitioners worldwide.

Is Nesplora a public or private company?

Nesplora is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Nesplora founded?

Nesplora was founded in 2008. It employs 11 to 50 people.

Where is Nesplora based?

Nesplora is headquartered in Donostia-san Sebastián, Spain, in the Europe region.

How does Nesplora make money?

Four revenue lines are on record. Subscription Plans (Essential, Professional) is the primary driver. The others are BITS Plan (Pay-per-use), enterprise Licenses and reactivation Fees.

Who are Nesplora's main competitors?

Direct peers on record are Creyos (formerly Cambridge Brain Sciences), CNS Vital Signs and Akili Interactive. Broad incumbents are Pear Therapeutics (precedent), PAR (Psychological Assessment Resources), Pearson Clinical Assessment and Posit Science (BrainHQ). Emerging players are Altoida, Winterlight Labs and Mindstrong (precedent).

Does Nesplora have an API?

No public API is recorded for Nesplora.

What industry is Nesplora in?

Nesplora's product category is Neuropsychological Assessment Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals